(15) reported dose-dependent variation in the efficacy of anti–CTLA-4 in water-drinking septic animals, where a low dose (50 μg) was beneficial and a high dose (200 μg) was harmful to sepsis survival. This evidence concerns the gene CTLA4 and Sepsis.